Olema Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 12.14 M | $151.91 M | 16.91% | 11.63% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 8.67 M | $108.47 M | 8.10% | 8.30% |
| JUPITER TOPCO LLC | 08/14/2026 | 7.09 M | $88.80 M | 100.00% | 6.79% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/14/2026 | 7.09 M | $88.64 M | -5.19% | 6.78% |
| BLACKROCK, INC. | 08/07/2026 | 6.71 M | $84.00 M | 18.80% | 6.43% |
| BVF INC/IL | 08/14/2026 | 5.30 M | $66.25 M | 0.00% | 5.07% |
| SIREN, L.L.C. | 08/13/2026 | 4.86 M | $60.76 M | 2.10% | 4.65% |
| STATE STREET CORP | 09/22/2026 | 4.32 M | $53.99 M | 9.61% | 4.20% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.34 M | $41.80 M | 8.36% | 3.20% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 3.21 M | $40.14 M | 0.00% | 3.07% |
| FRANKLIN TEMPLETON INC | 08/13/2026 | 2.35 M | $29.39 M | 92.75% | 2.25% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2026 | 2.15 M | $26.90 M | -44.87% | 2.06% |
| MORGAN STANLEY | 08/13/2026 | 1.83 M | $22.92 M | 50.72% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.82 M | $22.76 M | 17.78% | 1.74% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.66 M | $20.81 M | 180.46% | 1.59% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.57 M | $19.62 M | 49.96% | 1.50% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 1.50 M | $18.77 M | 100.00% | 1.44% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.42 M | $17.72 M | 30.87% | 1.36% |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 08/14/2026 | 1.36 M | $16.95 M | 0.00% | 1.30% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 08/14/2026 | 1.20 M | $15.01 M | 40.35% | 1.15% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.13 M | $14.15 M | -3.25% | 1.08% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 1.07 M | $13.40 M | 1,406.11% | 1.03% |
| DUQUESNE FAMILY OFFICE LLC | 08/14/2026 | 986.83 K | $12.35 M | 0.00% | 0.94% |
| DEFILADE CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 924.76 K | $11.57 M | -38.54% | 0.89% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 840.65 K | $10.52 M | 1,365.51% | 0.80% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 826.57 K | $10.34 M | -30.12% | 0.79% |
| CANDRIAM S.C.A. | 08/13/2026 | 751.13 K | $9.39 M | -1.10% | 0.72% |
| WOODLINE PARTNERS LP | 08/14/2026 | 751.03 K | $9.40 M | -49.32% | 0.72% |
| NORTHERN TRUST CORP | 08/13/2026 | 674.95 K | $8.44 M | 18.42% | 0.65% |
| VIVO CAPITAL, LLC | 08/14/2026 | 671.84 K | $8.40 M | 0.00% | 0.64% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 663.32 K | $8.30 M | 112.05% | 0.64% |
| CITADEL ADVISORS LLC | 09/02/2026 | 641.83 K | $8.03 M | -29.11% | 0.61% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 615.47 K | $7.70 M | -16.67% | 0.59% |
| READYSTATE ASSET MANAGEMENT LP | 08/14/2026 | 593.83 K | $7.43 M | 100.00% | 0.57% |
| JONES HILL CAPITAL LP | 08/13/2026 | 574.17 K | $7.18 M | 100.00% | 0.55% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 566.40 K | $7.09 M | 265.96% | 0.54% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 526.45 K | $6.59 M | -20.80% | 0.50% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 518.34 K | $6.48 M | 11.10% | 0.50% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 518.34 K | $6.48 M | 100.00% | 0.50% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 420.21 K | $5.26 M | -12.73% | 0.40% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 418.55 K | $5.24 M | -2.33% | 0.40% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 415.06 K | $5.19 M | 15.84% | 0.40% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 383.28 K | $4.79 M | -35.94% | 0.37% |
| SEB ASSET MANAGEMENT AB | 08/04/2026 | 339.46 K | $4.25 M | 0.00% | 0.33% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 334.88 K | $4.19 M | -34.17% | 0.32% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 296.72 K | $3.71 M | -1.01% | 0.28% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 235.18 K | $2.94 M | 38.03% | 0.23% |
| UBS GROUP AG | 08/13/2026 | 222.87 K | $2.79 M | -42.12% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 222.18 K | $2.78 M | 14.83% | 0.21% |
| PIER CAPITAL, LLC | 08/05/2026 | 220.70 K | $2.76 M | 62.15% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 247 institutional investors and hedge funds held shares of Olema Pharmaceuticals Inc. The most heavily invested institutionals were:
DIMENSIONAL FUND ADVISORS LP: 1.55 M
Candriam S.C.A.: 1.18 M
Hennion & Walsh Asset Management, Inc.: 421,061
SEB Asset Management AB: 339,461
DekaBank Deutsche Girozentrale: 160,000
ALPS ADVISORS INC: 115,947
99.65% of Olema Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 121.20 M shares in the last 24 months. This purchase volume represents approximately $1.94 B in transactions.